Insider filing · TBPH

Eran Broshy sold $809K of Theravance Biopharma (TBPH)

Executed Nov 11 2025, disclosed Nov 14 2025, 3 days later, against a two-business-day limit.

Returns are measured on stock purchases only.

EB Eran Broshy Director profile →

Eran Broshy (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales, 1 filed past the two-business-day deadline), most often in Theravance Biopharma, Inc. (TBPH). The largest single filing was $1.1M of TBPH (59,000 sh across 3 lots, as filed), executed Nov 11 2025.

TBPH Theravance Biopharma, Inc. TBPH · Healthcare · 10 filings in 24 months ticker →

Healthcare · Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→